Policy & Regulation Reporter
Marcus covers cannabis policy, federal and state legislation, and the regulatory landscape shaping the legal market. He has spent years tracking drug policy reform across all 50 states and reports on the legal frameworks that affect businesses and consumers.
A detailed breakdown of cannabis advertising and marketing regulations across legal states in 2026, covering prohibited claims, media restrictions, packaging rules, and compliance strategies.
An overview of legal protections available to cannabis industry workers in 2026, covering workplace safety, wage and hour rights, anti-discrimination protections, unionization efforts, and the gaps that remain.
How cannabis rescheduling to Schedule III affects federal employees, security clearance holders, and applicants in 2026 — what has changed, what hasn't, and how to navigate the evolving policy landscape.
A comprehensive, up-to-date guide to cannabis legalization status in every US state — covering recreational, medical, and CBD-only programs, plus key pending legislation.
Kentucky's medical cannabis program launched on January 1, 2026. Three months in, patient enrollment, dispensary openings, and early supply challenges paint a complex picture of the state's rollout.
An analysis of how international treaty obligations — including the 1961 Single Convention on Narcotic Drugs — complicate US cannabis legalization and what diplomatic options exist for reform.
An analysis of cannabis industry lobbying spending in 2026, covering major organizations, corporate lobbying, key legislative targets, and how lobbying dollars are shaping cannabis policy at federal and state levels.
South Dakota voters have twice approved cannabis legalization measures, and twice state politicians have blocked or undermined them. A look at the ongoing struggle between voter will and political resistance in one of America's most contested cannabis battlegrounds.
A comprehensive look at cannabis product recalls in 2026, including common contamination issues, labeling failures, regulatory responses, and what consumers should know to protect themselves.
Georgia's medical cannabis program takes a significant step forward as the state adds new qualifying conditions, increases dispensary licenses, and raises the THC oil possession limit.
An in-depth look at the growing cannabis labor movement in 2026, including union drives at major operators, worker demands around wages and safety, and the political dynamics shaping cannabis labor relations.
An update on the state-level interstate cannabis commerce pilot programs — which states are participating, what the legal framework looks like, early results, and the federal barriers that remain.
An analysis of cannabis social equity fund performance across states, examining how effectively these programs are addressing the disproportionate impact of prohibition on marginalized communities.
Millions of Americans still carry cannabis convictions on their records despite legalization. We examine which states are delivering on expungement promises and which are falling short.
An analysis of ongoing efforts to standardize cannabis testing laboratory practices, the problems caused by inconsistent standards, and reform initiatives aimed at creating reliable, uniform testing nationwide.
An in-depth look at how tribal sovereignty is enabling Native American nations to develop cannabis industries on their own terms, the legal framework involved, and the economic impact on tribal communities.
An investigation into the growing problem of cannabis testing labs inflating THC potency results to win business from cultivators, and why regulators are struggling to stop it.
Missouri's cannabis tax revenue has blown past projections by 40%, creating a windfall that highlights both the opportunity and the policy challenges of legalization.
States banning pre-employment cannabis testing, impairment vs presence testing, safety-sensitive positions, and the legal landscape for off-duty cannabis use — the 2026 employer guide.
The DEA has officially published its proposed rule to reschedule cannabis from Schedule I to Schedule III. Here's what changes, what doesn't, and what happens next.
Illinois reaches $5 billion in cumulative recreational cannabis sales since 2020, establishing itself as the dominant cannabis market in the Midwest.
Oregon's two-year-old psilocybin therapy program is producing data that could reshape cannabis regulation nationwide. The surprising lessons from America's psychedelic frontier.
THC blood levels don't reliably indicate impairment, leaving law enforcement and lawmakers struggling. We examine oral fluid testing, per se limits by state, and the quest for a cannabis breathalyzer.
An investigation into cannabis testing lab failures in 2026 — from potency inflation and contaminated products reaching dispensary shelves to regulatory enforcement gaps and emerging reform efforts.
The USDA's proposed hemp regulation update would close the THCA loophole, threatening a $4 billion unregulated market. Here's what operators need to know.
Florida becomes the first state to surpass 1 million active medical cannabis patients, as the state's recreational debate intensifies ahead of 2026 legislative session.
The SAFE Banking Act passes the Senate Banking Committee with bipartisan support, moving closer than ever to giving cannabis businesses access to financial services.
A new bipartisan bill in Pennsylvania's legislature could make it the 25th state with legal recreational cannabis. Here's what the proposal includes.
Ohio's adult-use cannabis market hits $500 million in sales just 10 months after launch, outpacing projections and signaling massive demand in the Midwest.
Arizona's cannabis market has quietly become one of America's most successful, crossing $2 billion in annual sales. Here's what makes the Grand Canyon State's approach work — and what other states can learn.
Federal cannabis testing labs are drowning in a years-long backlog, delaying research approvals, rescheduling decisions, and product safety testing. Here's how the bottleneck formed and who's paying the price.
With wholesale flower prices crashing below $800 per pound and dispensaries closing weekly, Michigan's race to the bottom is sending shockwaves across the Midwest — and creating unexpected winners.
Cannabis rescheduling impact on prices, banking, taxes, and access. What Schedule III means for the industry, consumers, and state markets.
A comprehensive look at the cannabis industry in 2026 — market size, new states, federal policy, price trends, product innovation, and investment outlook.
Pre-rolls vs packing your own — we break down cost per session, quality differences, convenience, and when each option actually wins.
Medical and recreational cannabis differ in taxes, potency limits, product access, and purchase limits. Here's when a med card is worth the investment.
A real comparison of dispensary vs street prices for cannabis, covering quality, safety, taxes, and when the legal market actually wins on value.
Everything you need to know about New Jersey dispensaries in 2026 — locations, pricing, wait times, tax structure, and how NJ compares to NY.
THCA flower is technically legal hemp that converts to THC when smoked. Here's how the loophole works, which states allow it, and what the DEA thinks.
Save 20-40% on cannabis with these 15 dispensary money-saving strategies. Loyalty programs, happy hours, bulk deals, and timing tricks.
Current cannabis prices across the US in 2026 — average costs for flower, edibles, concentrates, and vapes broken down by state, quality, and product type.
New York expands cannabis delivery licenses to all 62 counties. How statewide delivery reshapes a $7B market for 20 million residents.
Oregon and California signed the first interstate cannabis commerce pilot agreement.
Germany now has 500+ cannabis social clubs one year after legalization. How the model works, what went wrong, and its EU impact.
The Florida Supreme Court killed the 2026 legalization effort.
Despite the December 2025 executive order, DEA says cannabis remains Schedule I. Here's what actually changed, what didn't, and realistic timelines.
Virginia approved retail cannabis sales launching January 2027 with a 6% tax and $10M license fees. Here's how it reshapes the East Coast map.
Seven years after first passing the House, cannabis banking reform remains stalled.
The Show-Me State has become the Midwest's cannabis kingpin, blowing past projections with $2 billion in cumulative sales.
New York's Office of Cannabis Management padlocked over 1,000 illegal cannabis shops this quarter. But for every store that closes, two more open.
Thailand stunned the world when it decriminalized cannabis in 2022.
After decades of the federal government blocking cannabis science, NIH funding for cannabinoid research reached $300M in FY2026 — a 500% increase from...
Multi-state operators collectively owe $1.6 billion in 280E-related taxes. Now the IRS is fighting to keep every penny — even as rescheduling looms.
Ghana officially launched its Cannabis Regulatory Programme in February 2026, joining a growing list of African and European nations building legal...
A federal redefinition of hemp takes effect November 12, 2026, making delta-8, THCA flower, and most hemp-derived THC products illegal overnight.
States award cannabis licenses through lotteries, merit systems, and hybrid models. Some are genuinely fair. Others are rigged by design.
Even driving from one legal state to another legal state with cannabis is a federal crime.
Cannabis is legal in your state. You're on your own property. But your landlord says no smoking. Who wins?
A presidential pardon does not erase your record. Expungement does — but only in some states.
From a $25 fine in New York to a felony in Idaho, cannabis possession penalties vary wildly across America.
Some states set THC blood limits at 5 ng/mL. Others have zero-tolerance policies where any detectable THC — even from last week — means a DUI.
The USDA's proposed American Hemp Appellation Program would create geographic quality designations for hemp — similar to wine AVAs.
From Schedule I classification in 1970 to the DEA's 2025 review, trace every federal action that has shaped cannabis policy in the United States — and...
Both chambers of the Virginia legislature have advanced bills to legalize recreational marijuana sales, setting up negotiations on a start date. Gov.
Justices from both ideological wings questioned the government's argument that marijuana use justifies stripping Second Amendment rights, with some...
The Secure and Fair Enforcement Banking Act passed the Senate Banking Committee 17-7, marking the closest cannabis banking reform has ever come to...
Oregon has officially begun its interstate cannabis trade pilot program with Colorado, allowing licensed operators to ship product across state lines...
Pennsylvania's Senate advances a bipartisan recreational cannabis bill with a 6% state tax and automatic expungement provisions, positioning the...
Germany legalized cannabis possession and home cultivation in 2024, creating the biggest legal cannabis market in Europe.
Over 1.3 million veterans use cannabis for PTSD, chronic pain, and TBI — but the VA still can't recommend or prescribe it.
Millions of Americans carry cannabis convictions that are now legal.
Florida's adult-use cannabis market is projected to become the largest in the U.S. overnight.
Between state excise taxes, local surcharges, and standard sales tax, cannabis consumers are paying 25% to 45% in total taxes.
Ohio's adult-use cannabis market reached $100 million in quarterly sales faster than any state before it.
The DEA's final rulemaking on moving cannabis from Schedule I to Schedule III has entered its last phase.
Federal rescheduling doesn't legalize cannabis — it moves it into a regulatory framework that could collide with 24 state recreational programs.
The 2025 Farm Bill reauthorization targets the Delta-8 and THCA loophole that created a multi-billion-dollar unregulated market.
Recreational, medical, decriminalized, or prohibited — the complete legal status of cannabis in all 50 states, updated for 2026.
Can your employer fire you for legal cannabis use? It depends on your state, your industry, and when you consumed.
Delta-8 THC is psychoactive, widely available, and exists in a federal legal gray area.
A comprehensive timeline of cannabis legalization in America — from the Marihuana Tax Act to the War on Drugs to state-by-state reform and federal...
A data-driven analysis of cannabis social equity programs across the US — license outcomes, funding gaps, ownership demographics, and the structural...
Cannabis businesses operate in a $30B+ industry but can't get basic bank accounts.
Examining the evidence on cannabis legalization and opioid outcomes — prescription rates, overdose deaths, substitution patterns, and what the data...
Cannabis intelligence delivered to your inbox. No fluff, no stereotypes — just the news, data, and analysis that matters.
Free · No spam · Unsubscribe anytime